Company
Molecular Stethoscope
We need a revolution in diagnostics to match the recent innovations in therapeutics and treatments.
Also known as Superfluid
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- South San Francisco, United States
Claim, correct or request removal
Record updated 28 September 2026
About
Superfluid is developing the first high-performance, predictive blood-based test for Alzheimer’s Disease (AD) and related dementias that directly assays mRNA transcripts from the brain via its platform technology of cell-free messenger RNA (cf-mRNA) analysis and machine learning.
Funding snapshot
- Latest round
- Undisclosed2023-09
Funding rounds
- Round, 2023
- 2023-09
Products
- Other
- blood-based test for Alzheimer’s Disease (AD) and related dementias
Loading relationship preview